Rank | Gene Set | Z-score |
---|---|---|
1 | actin-myosin filament sliding (GO:0033275) | 7.30208580 |
2 | muscle filament sliding (GO:0030049) | 7.30208580 |
3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.85637263 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.57010420 |
5 | skeletal muscle contraction (GO:0003009) | 6.22745718 |
6 | regulation of skeletal muscle contraction (GO:0014819) | 6.15091474 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.94638519 |
8 | actin-mediated cell contraction (GO:0070252) | 5.86648263 |
9 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.34486659 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.31602854 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.31602854 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.98425589 |
13 | definitive hemopoiesis (GO:0060216) | 4.93129661 |
14 | creatine metabolic process (GO:0006600) | 4.84186615 |
15 | positive regulation of B cell differentiation (GO:0045579) | 4.78366734 |
16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.76359615 |
17 | striated muscle contraction (GO:0006941) | 4.74734471 |
18 | positive regulation of respiratory burst (GO:0060267) | 4.73886410 |
19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.68520826 |
20 | megakaryocyte development (GO:0035855) | 4.56913754 |
21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.48776278 |
22 | actin filament-based movement (GO:0030048) | 4.38882423 |
23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.35817663 |
24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33644103 |
25 | regulation of relaxation of muscle (GO:1901077) | 4.21063479 |
26 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.15825967 |
27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.15078720 |
28 | positive regulation of granulocyte differentiation (GO:0030854) | 4.11301850 |
29 | regulation of B cell differentiation (GO:0045577) | 4.05038948 |
30 | B cell receptor signaling pathway (GO:0050853) | 4.04988625 |
31 | mature B cell differentiation involved in immune response (GO:0002313) | 3.92487904 |
32 | positive thymic T cell selection (GO:0045059) | 3.91630270 |
33 | response to inactivity (GO:0014854) | 3.89836268 |
34 | relaxation of muscle (GO:0090075) | 3.78265578 |
35 | carnitine transmembrane transport (GO:1902603) | 3.60218978 |
36 | carnitine transport (GO:0015879) | 3.59753122 |
37 | amino-acid betaine transport (GO:0015838) | 3.59753122 |
38 | muscle contraction (GO:0006936) | 3.57307751 |
39 | skeletal muscle adaptation (GO:0043501) | 3.56365564 |
40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55038122 |
41 | negative regulation of cell killing (GO:0031342) | 3.55038122 |
42 | regulation of granulocyte differentiation (GO:0030852) | 3.53697052 |
43 | embryonic hemopoiesis (GO:0035162) | 3.52715260 |
44 | skeletal muscle fiber development (GO:0048741) | 3.51359658 |
45 | mast cell activation (GO:0045576) | 3.48463604 |
46 | glycogen catabolic process (GO:0005980) | 3.48228205 |
47 | mature B cell differentiation (GO:0002335) | 3.46200918 |
48 | neuronal action potential propagation (GO:0019227) | 3.45422397 |
49 | cardiac muscle hypertrophy (GO:0003300) | 3.42724346 |
50 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.40500143 |
51 | Peyers patch development (GO:0048541) | 3.40500143 |
52 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.40036111 |
53 | negative T cell selection (GO:0043383) | 3.35274444 |
54 | negative thymic T cell selection (GO:0045060) | 3.34972349 |
55 | angiogenesis involved in wound healing (GO:0060055) | 3.34318208 |
56 | mast cell activation involved in immune response (GO:0002279) | 3.33684115 |
57 | mast cell degranulation (GO:0043303) | 3.33684115 |
58 | oxygen transport (GO:0015671) | 3.33471221 |
59 | muscle system process (GO:0003012) | 3.31962467 |
60 | response to muscle activity (GO:0014850) | 3.31097468 |
61 | cardiac myofibril assembly (GO:0055003) | 3.31001905 |
62 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.29953120 |
63 | carnitine shuttle (GO:0006853) | 3.29756964 |
64 | negative regulation of granulocyte differentiation (GO:0030853) | 3.28397912 |
65 | striated muscle hypertrophy (GO:0014897) | 3.26851975 |
66 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.25904370 |
67 | glucan catabolic process (GO:0009251) | 3.24848946 |
68 | regulation of respiratory burst (GO:0060263) | 3.24536402 |
69 | lymph node development (GO:0048535) | 3.24339028 |
70 | positive T cell selection (GO:0043368) | 3.19289796 |
71 | cellular polysaccharide catabolic process (GO:0044247) | 3.17109133 |
72 | glycogen biosynthetic process (GO:0005978) | 3.17054205 |
73 | glucan biosynthetic process (GO:0009250) | 3.17054205 |
74 | positive regulation of cation channel activity (GO:2001259) | 3.16147871 |
75 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.16129630 |
76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.15693310 |
77 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.14810394 |
78 | regulation of actin filament-based movement (GO:1903115) | 3.14612139 |
79 | myotube cell development (GO:0014904) | 3.14275035 |
80 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.12204945 |
81 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.12204945 |
82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11872632 |
83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.06899836 |
84 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06637624 |
85 | negative regulation of muscle contraction (GO:0045932) | 3.05700984 |
86 | actomyosin structure organization (GO:0031032) | 3.05579781 |
87 | response to interleukin-15 (GO:0070672) | 3.04917056 |
88 | neurotransmitter catabolic process (GO:0042135) | 3.04822469 |
89 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03374599 |
90 | labyrinthine layer development (GO:0060711) | 3.02525352 |
91 | striated muscle adaptation (GO:0014888) | 3.01974262 |
92 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.01130654 |
93 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.00891086 |
94 | thymic T cell selection (GO:0045061) | 2.93165992 |
95 | polysaccharide catabolic process (GO:0000272) | 2.92900543 |
96 | regulation of striated muscle contraction (GO:0006942) | 2.91704231 |
97 | regulation of sarcomere organization (GO:0060297) | 2.90909770 |
98 | T cell homeostasis (GO:0043029) | 2.90273081 |
99 | muscle hypertrophy (GO:0014896) | 2.90099826 |
100 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.89306211 |
101 | natural killer cell differentiation (GO:0001779) | 2.88536948 |
102 | skeletal muscle tissue development (GO:0007519) | 2.87521089 |
103 | fatty acid transmembrane transport (GO:1902001) | 2.87318825 |
104 | cellular response to zinc ion (GO:0071294) | 2.86965765 |
105 | T cell selection (GO:0045058) | 2.86227650 |
106 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.85743352 |
107 | regulation of regulatory T cell differentiation (GO:0045589) | 2.82389866 |
108 | quaternary ammonium group transport (GO:0015697) | 2.81016644 |
109 | regulation of erythrocyte differentiation (GO:0045646) | 2.80904834 |
110 | regulation of membrane repolarization (GO:0060306) | 2.80076543 |
111 | regulation of cell communication by electrical coupling (GO:0010649) | 2.79883991 |
112 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.79679346 |
113 | macroautophagy (GO:0016236) | 2.79076987 |
114 | response to type I interferon (GO:0034340) | 2.75829368 |
115 | myofibril assembly (GO:0030239) | 2.75533215 |
116 | leukocyte homeostasis (GO:0001776) | 2.75419352 |
117 | cellular response to interleukin-15 (GO:0071350) | 2.75355289 |
118 | lymphocyte homeostasis (GO:0002260) | 2.74964021 |
119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72744424 |
120 | muscle fiber development (GO:0048747) | 2.71674256 |
121 | barbed-end actin filament capping (GO:0051016) | 2.71064989 |
122 | necroptotic process (GO:0070266) | 2.69696019 |
123 | regulation of ARF protein signal transduction (GO:0032012) | 2.67755214 |
124 | mitotic cell cycle arrest (GO:0071850) | 2.67704522 |
125 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67585095 |
126 | sarcomere organization (GO:0045214) | 2.67217799 |
127 | potassium ion import (GO:0010107) | 2.66838824 |
128 | cellular response to type I interferon (GO:0071357) | 2.66447086 |
129 | type I interferon signaling pathway (GO:0060337) | 2.66447086 |
130 | positive regulation of gluconeogenesis (GO:0045722) | 2.66434320 |
131 | interkinetic nuclear migration (GO:0022027) | 2.66361652 |
132 | pinocytosis (GO:0006907) | 2.66226058 |
133 | myeloid cell development (GO:0061515) | 2.65860723 |
134 | sodium ion export (GO:0071436) | 2.64935583 |
135 | glycogen metabolic process (GO:0005977) | 2.64131883 |
136 | negative regulation of stress fiber assembly (GO:0051497) | 2.64100111 |
137 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.63572689 |
138 | myeloid dendritic cell activation (GO:0001773) | 2.63213820 |
139 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.63012887 |
140 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62610393 |
141 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.60897757 |
142 | muscle hypertrophy in response to stress (GO:0003299) | 2.60897757 |
143 | cardiac muscle adaptation (GO:0014887) | 2.60897757 |
144 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.59724464 |
145 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.59724464 |
146 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.59661110 |
147 | regulation of sequestering of triglyceride (GO:0010889) | 2.59463445 |
148 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.59432655 |
149 | regulation of germinal center formation (GO:0002634) | 2.59055025 |
150 | relaxation of smooth muscle (GO:0044557) | 2.58956410 |
151 | auditory receptor cell stereocilium organization (GO:0060088) | 2.58239078 |
152 | cellular glucan metabolic process (GO:0006073) | 2.58130056 |
153 | glucan metabolic process (GO:0044042) | 2.58130056 |
154 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.57983438 |
155 | cardiac muscle contraction (GO:0060048) | 2.57911993 |
156 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.56095216 |
157 | response to epinephrine (GO:0071871) | 2.55883070 |
158 | regulation of synapse structural plasticity (GO:0051823) | 2.55493618 |
159 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.55406122 |
160 | plasma membrane repair (GO:0001778) | 2.55260765 |
161 | relaxation of cardiac muscle (GO:0055119) | 2.54915662 |
162 | lymphoid progenitor cell differentiation (GO:0002320) | 2.54248043 |
163 | germinal center formation (GO:0002467) | 2.54077856 |
164 | NADH metabolic process (GO:0006734) | 2.53260705 |
165 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.53197279 |
166 | 2-oxoglutarate metabolic process (GO:0006103) | 2.51883378 |
167 | response to interferon-alpha (GO:0035455) | 2.51745429 |
168 | muscle tissue morphogenesis (GO:0060415) | 2.49863525 |
169 | positive regulation of vasculogenesis (GO:2001214) | 2.49612161 |
170 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.49322476 |
171 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.49280265 |
172 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.49108639 |
173 | heparin biosynthetic process (GO:0030210) | 2.48573998 |
174 | heparin metabolic process (GO:0030202) | 2.48573998 |
175 | mannose metabolic process (GO:0006013) | 2.48046222 |
176 | cellular response to electrical stimulus (GO:0071257) | 2.47961897 |
177 | organic cation transport (GO:0015695) | 2.47595278 |
178 | negative regulation of necroptotic process (GO:0060546) | 2.47472572 |
179 | regulation of female receptivity (GO:0045924) | 2.47231673 |
180 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.47188162 |
181 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.46846996 |
182 | regulation of response to interferon-gamma (GO:0060330) | 2.45835315 |
183 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44005156 |
184 | regulation of T cell tolerance induction (GO:0002664) | 2.43652938 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.30053587 |
2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.88971646 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.43698885 |
4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.18177589 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.79470356 |
6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.51519275 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.26309278 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25789137 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.06827598 |
10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.06450707 |
11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.01520391 |
12 | MYC_22102868_ChIP-Seq_BL_Human | 2.72077126 |
13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67579642 |
14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.61056952 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44558926 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38292298 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37554727 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36147709 |
19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.32519304 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32232378 |
21 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.29644909 |
22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.26420712 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 2.26276671 |
24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25793540 |
25 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21755473 |
26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.17859027 |
27 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15909543 |
28 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.14518396 |
29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11707072 |
30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10950755 |
31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09644075 |
32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03855727 |
33 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02934097 |
34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02809479 |
35 | GATA1_19941826_ChIP-Seq_K562_Human | 2.01761559 |
36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97276368 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96671097 |
38 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95555519 |
39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95498932 |
40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.95493064 |
41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91509389 |
42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89342970 |
43 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.88547889 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87325237 |
45 | * MYB_26560356_Chip-Seq_TH1_Human | 1.86232971 |
46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79403638 |
47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77962058 |
48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77634807 |
49 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77151995 |
50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.76729665 |
51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74262504 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72781430 |
53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.68148286 |
54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66565489 |
55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62355031 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61204515 |
57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60930070 |
58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59393654 |
59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57915622 |
60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55426038 |
61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54988776 |
62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54482149 |
63 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54260935 |
64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.52300589 |
65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51499643 |
66 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49251515 |
67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48701116 |
68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47276119 |
69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46485165 |
70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46430920 |
71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43623604 |
72 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41947064 |
73 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41879028 |
74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39446738 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34082330 |
76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34069456 |
77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32495586 |
78 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32309099 |
79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26559578 |
80 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26315942 |
81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24817746 |
82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22477174 |
83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21571144 |
84 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20065183 |
85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19575942 |
86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19346895 |
87 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.17811747 |
88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16849990 |
89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.16256130 |
90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15949204 |
91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15808073 |
92 | MAF_26560356_Chip-Seq_TH2_Human | 1.15024855 |
93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15008663 |
94 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14853717 |
95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13798968 |
96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13105703 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12962449 |
98 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12944892 |
99 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12691719 |
100 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12395902 |
101 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12364831 |
102 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12230678 |
103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11962280 |
104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11642938 |
105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10161345 |
106 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10136542 |
107 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09707838 |
108 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07123704 |
109 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05984824 |
110 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05535154 |
111 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05203078 |
112 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.04980991 |
113 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04823182 |
114 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04408693 |
115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03270707 |
116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02861373 |
117 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02861373 |
118 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02395382 |
119 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02226623 |
120 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.02060514 |
121 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01100048 |
122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01017112 |
123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00541985 |
124 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00438417 |
125 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00266009 |
126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99791018 |
127 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99575791 |
128 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99575791 |
129 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99351436 |
130 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99218523 |
131 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98022701 |
132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96540313 |
133 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96314646 |
134 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96314646 |
135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96293871 |
136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95602598 |
137 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95460596 |
138 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95035810 |
139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94631018 |
140 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94548564 |
141 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.94393400 |
142 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94141436 |
143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94008397 |
144 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92993234 |
145 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92207983 |
146 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.91964759 |
147 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90970138 |
148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90560102 |
149 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89449090 |
150 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89252616 |
151 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89242036 |
152 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89088073 |
153 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88687577 |
154 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88523312 |
155 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88381515 |
156 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88309579 |
157 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87960301 |
158 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87438540 |
159 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87087943 |
160 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86889679 |
161 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86619005 |
162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86396116 |
163 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85542870 |
164 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85248756 |
165 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84859880 |
166 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84004584 |
167 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83996169 |
168 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83828982 |
169 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83585940 |
170 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83533809 |
171 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83491172 |
172 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83402612 |
173 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83314207 |
174 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.82181152 |
175 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82105188 |
176 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82012424 |
177 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.81934012 |
178 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81845874 |
179 | * GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.81664288 |
180 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80339950 |
181 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80334327 |
182 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78625795 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004147_increased_porphyrin_level | 3.63196148 |
2 | MP0001835_abnormal_antigen_presentation | 3.16383664 |
3 | MP0000685_abnormal_immune_system | 3.14748778 |
4 | MP0004084_abnormal_cardiac_muscle | 2.86062774 |
5 | MP0005671_abnormal_response_to | 2.79453475 |
6 | MP0004510_myositis | 2.76726890 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 2.61621631 |
8 | MP0002396_abnormal_hematopoietic_system | 2.57671301 |
9 | MP0003763_abnormal_thymus_physiology | 2.48594063 |
10 | MP0003183_abnormal_peptide_metabolism | 2.46820514 |
11 | MP0000751_myopathy | 2.38503702 |
12 | MP0000465_gastrointestinal_hemorrhage | 2.28849963 |
13 | MP0000759_abnormal_skeletal_muscle | 2.25229142 |
14 | MP0004215_abnormal_myocardial_fiber | 2.21805658 |
15 | MP0000013_abnormal_adipose_tissue | 2.21351832 |
16 | MP0004808_abnormal_hematopoietic_stem | 2.21254932 |
17 | MP0002009_preneoplasia | 2.20692397 |
18 | MP0004036_abnormal_muscle_relaxation | 2.18909409 |
19 | MP0001800_abnormal_humoral_immune | 2.16663248 |
20 | MP0004130_abnormal_muscle_cell | 2.15784704 |
21 | MP0001790_abnormal_immune_system | 2.13536019 |
22 | MP0005387_immune_system_phenotype | 2.13536019 |
23 | MP0005464_abnormal_platelet_physiology | 2.13338481 |
24 | MP0004270_analgesia | 2.00662205 |
25 | MP0002332_abnormal_exercise_endurance | 2.00114402 |
26 | MP0002398_abnormal_bone_marrow | 1.95325948 |
27 | MP0002452_abnormal_antigen_presenting | 1.91311088 |
28 | MP0002420_abnormal_adaptive_immunity | 1.88510161 |
29 | MP0002166_altered_tumor_susceptibility | 1.85965074 |
30 | MP0001819_abnormal_immune_cell | 1.85042475 |
31 | MP0000749_muscle_degeneration | 1.83958853 |
32 | MP0003646_muscle_fatigue | 1.81584628 |
33 | MP0002723_abnormal_immune_serum | 1.75779266 |
34 | MP0009785_altered_susceptibility_to | 1.74770006 |
35 | MP0005174_abnormal_tail_pigmentation | 1.71138187 |
36 | MP0001873_stomach_inflammation | 1.70700505 |
37 | MP0000689_abnormal_spleen_morphology | 1.66898211 |
38 | MP0000716_abnormal_immune_system | 1.65891060 |
39 | MP0003866_abnormal_defecation | 1.64449223 |
40 | MP0005025_abnormal_response_to | 1.62986320 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.60956665 |
42 | MP0002909_abnormal_adrenal_gland | 1.60827835 |
43 | MP0003045_fibrosis | 1.59656775 |
44 | MP0002971_abnormal_brown_adipose | 1.58878870 |
45 | MP0005000_abnormal_immune_tolerance | 1.57843290 |
46 | MP0002722_abnormal_immune_system | 1.57367297 |
47 | MP0004484_altered_response_of | 1.56516588 |
48 | MP0002638_abnormal_pupillary_reflex | 1.51682432 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.50482892 |
50 | MP0010368_abnormal_lymphatic_system | 1.44920114 |
51 | MP0002419_abnormal_innate_immunity | 1.44861552 |
52 | MP0003828_pulmonary_edema | 1.43693735 |
53 | MP0009780_abnormal_chondrocyte_physiolo | 1.42582736 |
54 | MP0002429_abnormal_blood_cell | 1.42260076 |
55 | MP0005397_hematopoietic_system_phenotyp | 1.40386796 |
56 | MP0001545_abnormal_hematopoietic_system | 1.40386796 |
57 | MP0001853_heart_inflammation | 1.40258940 |
58 | MP0003300_gastrointestinal_ulcer | 1.39937214 |
59 | MP0001984_abnormal_olfaction | 1.39053739 |
60 | MP0000733_abnormal_muscle_development | 1.37288096 |
61 | MP0005058_abnormal_lysosome_morphology | 1.37137809 |
62 | MP0000703_abnormal_thymus_morphology | 1.36808312 |
63 | MP0005330_cardiomyopathy | 1.35884691 |
64 | MP0002106_abnormal_muscle_physiology | 1.34602663 |
65 | MP0003880_abnormal_central_pattern | 1.34097640 |
66 | MP0001661_extended_life_span | 1.32546796 |
67 | MP0005423_abnormal_somatic_nervous | 1.32044898 |
68 | MP0000569_abnormal_digit_pigmentation | 1.30551771 |
69 | MP0010630_abnormal_cardiac_muscle | 1.29793059 |
70 | MP0008569_lethality_at_weaning | 1.29514947 |
71 | MP0002127_abnormal_cardiovascular_syste | 1.29101013 |
72 | MP0001544_abnormal_cardiovascular_syste | 1.28903814 |
73 | MP0005385_cardiovascular_system_phenoty | 1.28903814 |
74 | MP0002876_abnormal_thyroid_physiology | 1.26039518 |
75 | MP0008775_abnormal_heart_ventricle | 1.25994094 |
76 | MP0009278_abnormal_bone_marrow | 1.25906062 |
77 | MP0000750_abnormal_muscle_regeneration | 1.25726579 |
78 | MP0001501_abnormal_sleep_pattern | 1.25142096 |
79 | MP0005075_abnormal_melanosome_morpholog | 1.23838184 |
80 | MP0003567_abnormal_fetal_cardiomyocyte | 1.23527778 |
81 | MP0004233_abnormal_muscle_weight | 1.23341592 |
82 | MP0002972_abnormal_cardiac_muscle | 1.23063688 |
83 | MP0010155_abnormal_intestine_physiology | 1.21941459 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 1.18563987 |
85 | MP0002006_tumorigenesis | 1.17135973 |
86 | MP0002405_respiratory_system_inflammati | 1.16934630 |
87 | MP0004185_abnormal_adipocyte_glucose | 1.16684845 |
88 | MP0002234_abnormal_pharynx_morphology | 1.16407363 |
89 | MP0003724_increased_susceptibility_to | 1.15077163 |
90 | MP0003172_abnormal_lysosome_physiology | 1.14438781 |
91 | MP0005451_abnormal_body_composition | 1.14402967 |
92 | MP0005666_abnormal_adipose_tissue | 1.14306079 |
93 | MP0005670_abnormal_white_adipose | 1.11750031 |
94 | MP0002148_abnormal_hypersensitivity_rea | 1.08896045 |
95 | MP0004087_abnormal_muscle_fiber | 1.08367768 |
96 | MP0002272_abnormal_nervous_system | 1.08331062 |
97 | MP0005535_abnormal_body_temperature | 1.07450672 |
98 | MP0002108_abnormal_muscle_morphology | 1.06074996 |
99 | MP0002095_abnormal_skin_pigmentation | 1.03402467 |
100 | MP0004145_abnormal_muscle_electrophysio | 1.02852754 |
101 | MP0001845_abnormal_inflammatory_respons | 1.02067084 |
102 | MP0005369_muscle_phenotype | 1.01850709 |
103 | MP0005375_adipose_tissue_phenotype | 1.01727890 |
104 | MP0002822_catalepsy | 1.01451343 |
105 | MP0003011_delayed_dark_adaptation | 1.01282248 |
106 | MP0000230_abnormal_systemic_arterial | 1.00223816 |
107 | MP0005266_abnormal_metabolism | 0.98009570 |
108 | MP0006276_abnormal_autonomic_nervous | 0.97657966 |
109 | MP0003137_abnormal_impulse_conducting | 0.96397306 |
110 | MP0001986_abnormal_taste_sensitivity | 0.96051879 |
111 | MP0000343_altered_response_to | 0.95095151 |
112 | MP0005620_abnormal_muscle_contractility | 0.93963313 |
113 | MP0009840_abnormal_foam_cell | 0.92468457 |
114 | MP0004085_abnormal_heartbeat | 0.91855644 |
115 | MP0005646_abnormal_pituitary_gland | 0.91843070 |
116 | MP0008877_abnormal_DNA_methylation | 0.91811382 |
117 | MP0003279_aneurysm | 0.91801976 |
118 | MP0003635_abnormal_synaptic_transmissio | 0.91620857 |
119 | MP0005645_abnormal_hypothalamus_physiol | 0.91430274 |
120 | MP0004947_skin_inflammation | 0.91011689 |
121 | MP0001502_abnormal_circadian_rhythm | 0.90927965 |
122 | MP0000003_abnormal_adipose_tissue | 0.90234239 |
123 | MP0006138_congestive_heart_failure | 0.90137781 |
124 | MP0002269_muscular_atrophy | 0.87878824 |
125 | MP0003436_decreased_susceptibility_to | 0.87640764 |
126 | MP0008995_early_reproductive_senescence | 0.87323892 |
127 | MP0002064_seizures | 0.86246535 |
128 | MP0008961_abnormal_basal_metabolism | 0.85392696 |
129 | MP0001879_abnormal_lymphatic_vessel | 0.85023327 |
130 | MP0002933_joint_inflammation | 0.84734450 |
131 | MP0002078_abnormal_glucose_homeostasis | 0.84152928 |
132 | MP0002734_abnormal_mechanical_nocicepti | 0.83873855 |
133 | MP0003075_altered_response_to | 0.82360823 |
134 | MP0004859_abnormal_synaptic_plasticity | 0.81432016 |
135 | MP0005409_darkened_coat_color | 0.81352171 |
136 | MP0003879_abnormal_hair_cell | 0.81217063 |
137 | MP0001486_abnormal_startle_reflex | 0.79463944 |
138 | MP0001440_abnormal_grooming_behavior | 0.79295518 |
139 | MP0009333_abnormal_splenocyte_physiolog | 0.77656449 |
140 | MP0008469_abnormal_protein_level | 0.77381955 |
141 | MP0001765_abnormal_ion_homeostasis | 0.75678430 |
142 | MP0006054_spinal_hemorrhage | 0.75605246 |
143 | MP0009745_abnormal_behavioral_response | 0.74595681 |
144 | MP0003690_abnormal_glial_cell | 0.73556745 |
145 | MP0000747_muscle_weakness | 0.73211496 |
146 | MP0005165_increased_susceptibility_to | 0.72534922 |
147 | MP0006082_CNS_inflammation | 0.71277359 |
148 | MP0003633_abnormal_nervous_system | 0.70484726 |
149 | MP0010329_abnormal_lipoprotein_level | 0.68308522 |
150 | MP0002063_abnormal_learning/memory/cond | 0.66521339 |
151 | MP0002118_abnormal_lipid_homeostasis | 0.61512431 |
152 | MP0005386_behavior/neurological_phenoty | 0.60089791 |
153 | MP0004924_abnormal_behavior | 0.60089791 |
154 | MP0005167_abnormal_blood-brain_barrier | 0.59026880 |
155 | MP0002138_abnormal_hepatobiliary_system | 0.57964585 |
156 | MP0005220_abnormal_exocrine_pancreas | 0.56403976 |
157 | MP0002067_abnormal_sensory_capabilities | 0.54824257 |
158 | MP0004043_abnormal_pH_regulation | 0.54563813 |
159 | MP0005334_abnormal_fat_pad | 0.54469213 |
160 | MP0005253_abnormal_eye_physiology | 0.53834958 |
161 | MP0005332_abnormal_amino_acid | 0.53587371 |
162 | MP0002229_neurodegeneration | 0.53568012 |
163 | MP0009046_muscle_twitch | 0.52675389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 9.09085176 |
2 | Nemaline bodies (HP:0003798) | 8.91544316 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.62205468 |
4 | Type 1 muscle fiber predominance (HP:0003803) | 6.36772921 |
5 | Distal arthrogryposis (HP:0005684) | 5.47075693 |
6 | Rhabdomyolysis (HP:0003201) | 4.81020071 |
7 | Myopathic facies (HP:0002058) | 4.49112895 |
8 | EMG: myopathic abnormalities (HP:0003458) | 4.40392308 |
9 | Muscle fiber splitting (HP:0003555) | 4.36373507 |
10 | Rimmed vacuoles (HP:0003805) | 4.24075048 |
11 | Myositis (HP:0100614) | 4.19517782 |
12 | Asymmetric septal hypertrophy (HP:0001670) | 4.03834521 |
13 | Chronic otitis media (HP:0000389) | 3.94098546 |
14 | Hyporeflexia of lower limbs (HP:0002600) | 3.89625102 |
15 | Ulnar deviation of the wrist (HP:0003049) | 3.72639889 |
16 | Panhypogammaglobulinemia (HP:0003139) | 3.68938530 |
17 | Round ear (HP:0100830) | 3.64621494 |
18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57310724 |
19 | Agammaglobulinemia (HP:0004432) | 3.50439792 |
20 | Recurrent bronchitis (HP:0002837) | 3.48147088 |
21 | Neck muscle weakness (HP:0000467) | 3.38024753 |
22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.37507200 |
23 | Difficulty running (HP:0009046) | 3.37421214 |
24 | Bundle branch block (HP:0011710) | 3.35021179 |
25 | Exercise-induced myalgia (HP:0003738) | 3.34309891 |
26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.25832187 |
27 | Frequent falls (HP:0002359) | 3.24472923 |
28 | Orchitis (HP:0100796) | 3.21723249 |
29 | Petechiae (HP:0000967) | 3.18470098 |
30 | Prolonged bleeding time (HP:0003010) | 3.11646169 |
31 | IgM deficiency (HP:0002850) | 3.08205774 |
32 | Retrobulbar optic neuritis (HP:0100654) | 3.07755624 |
33 | Optic neuritis (HP:0100653) | 3.07755624 |
34 | Atrial fibrillation (HP:0005110) | 3.06574751 |
35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.05010694 |
36 | Subaortic stenosis (HP:0001682) | 3.05010694 |
37 | Muscle stiffness (HP:0003552) | 3.02259555 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.00432491 |
39 | Absent phalangeal crease (HP:0006109) | 2.94628538 |
40 | Colitis (HP:0002583) | 2.92939014 |
41 | Supraventricular tachycardia (HP:0004755) | 2.91280580 |
42 | Thrombocytosis (HP:0001894) | 2.90862119 |
43 | Gastrointestinal inflammation (HP:0004386) | 2.90785959 |
44 | Primary atrial arrhythmia (HP:0001692) | 2.89603024 |
45 | Inflammation of the large intestine (HP:0002037) | 2.87693727 |
46 | Hyperkalemia (HP:0002153) | 2.83440906 |
47 | Supraventricular arrhythmia (HP:0005115) | 2.80947336 |
48 | EMG: neuropathic changes (HP:0003445) | 2.76851707 |
49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.76801605 |
50 | Sudden death (HP:0001699) | 2.76137088 |
51 | Gastrointestinal stroma tumor (HP:0100723) | 2.74412019 |
52 | Ventricular tachycardia (HP:0004756) | 2.71636521 |
53 | Generalized muscle weakness (HP:0003324) | 2.71121710 |
54 | Areflexia of lower limbs (HP:0002522) | 2.68179593 |
55 | Facial diplegia (HP:0001349) | 2.67366409 |
56 | Fatigue (HP:0012378) | 2.65104841 |
57 | Abnormality of the fingertips (HP:0001211) | 2.61232465 |
58 | Malignant hyperthermia (HP:0002047) | 2.53468224 |
59 | Calcaneovalgus deformity (HP:0001848) | 2.51872761 |
60 | Calf muscle hypertrophy (HP:0008981) | 2.50732625 |
61 | Fetal akinesia sequence (HP:0001989) | 2.49821420 |
62 | Atrioventricular block (HP:0001678) | 2.47355715 |
63 | Recurrent viral infections (HP:0004429) | 2.44860111 |
64 | Impaired platelet aggregation (HP:0003540) | 2.44650701 |
65 | Abnormal platelet function (HP:0011869) | 2.44650701 |
66 | Arterial thrombosis (HP:0004420) | 2.44516734 |
67 | Recurrent abscess formation (HP:0002722) | 2.40970017 |
68 | Abnormality of B cell number (HP:0010975) | 2.40403556 |
69 | B lymphocytopenia (HP:0010976) | 2.40403556 |
70 | Cellulitis (HP:0100658) | 2.40216200 |
71 | Abnormal finger flexion creases (HP:0006143) | 2.39841549 |
72 | Meningitis (HP:0001287) | 2.38117641 |
73 | Hypoproteinemia (HP:0003075) | 2.36973140 |
74 | Stomach cancer (HP:0012126) | 2.36633480 |
75 | Increased cerebral lipofuscin (HP:0011813) | 2.36303945 |
76 | Abnormality of the nasal mucosa (HP:0000433) | 2.36169086 |
77 | Recurrent fungal infections (HP:0002841) | 2.36167716 |
78 | Chest pain (HP:0100749) | 2.32702630 |
79 | Broad metatarsal (HP:0001783) | 2.32227453 |
80 | Papilledema (HP:0001085) | 2.29787364 |
81 | Eczematoid dermatitis (HP:0000976) | 2.28587346 |
82 | Lipoatrophy (HP:0100578) | 2.28127566 |
83 | Weak cry (HP:0001612) | 2.26627057 |
84 | Heart block (HP:0012722) | 2.26245268 |
85 | Deformed tarsal bones (HP:0008119) | 2.25072471 |
86 | Bulbar palsy (HP:0001283) | 2.23786037 |
87 | Keratoconjunctivitis sicca (HP:0001097) | 2.23299460 |
88 | T lymphocytopenia (HP:0005403) | 2.20512850 |
89 | Spinal canal stenosis (HP:0003416) | 2.19558400 |
90 | Abnormality of T cells (HP:0002843) | 2.15975609 |
91 | Increased IgE level (HP:0003212) | 2.14806993 |
92 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.12155175 |
93 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09775708 |
94 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09775708 |
95 | Distal lower limb muscle weakness (HP:0009053) | 2.07873421 |
96 | Encephalitis (HP:0002383) | 2.07448644 |
97 | Chronic diarrhea (HP:0002028) | 2.05081685 |
98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04182930 |
99 | Nonprogressive disorder (HP:0003680) | 2.03970439 |
100 | Thyroiditis (HP:0100646) | 2.03341637 |
101 | Ventricular fibrillation (HP:0001663) | 2.03218161 |
102 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02885612 |
103 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02570492 |
104 | Hyperphosphatemia (HP:0002905) | 2.02562229 |
105 | Dysostosis multiplex (HP:0000943) | 2.02231724 |
106 | Epistaxis (HP:0000421) | 2.01803832 |
107 | Palpitations (HP:0001962) | 2.01728491 |
108 | Gowers sign (HP:0003391) | 2.01204070 |
109 | Chronic sinusitis (HP:0011109) | 2.00812873 |
110 | Spontaneous hematomas (HP:0007420) | 2.00608163 |
111 | Keratoconjunctivitis (HP:0001096) | 1.99702518 |
112 | Abnormal EKG (HP:0003115) | 1.99260986 |
113 | Abnormality of T cell number (HP:0011839) | 1.98643630 |
114 | Dysmetric saccades (HP:0000641) | 1.98289051 |
115 | Febrile seizures (HP:0002373) | 1.97757056 |
116 | Dilated cardiomyopathy (HP:0001644) | 1.95960670 |
117 | Focal motor seizures (HP:0011153) | 1.94335213 |
118 | Amaurosis fugax (HP:0100576) | 1.93687574 |
119 | Lymphopenia (HP:0001888) | 1.93050018 |
120 | Growth hormone excess (HP:0000845) | 1.92044604 |
121 | Exercise-induced muscle cramps (HP:0003710) | 1.91467024 |
122 | Nasal polyposis (HP:0100582) | 1.90942596 |
123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.90941697 |
124 | Abnormal atrioventricular conduction (HP:0005150) | 1.90816078 |
125 | Scapular winging (HP:0003691) | 1.90127245 |
126 | Increased connective tissue (HP:0009025) | 1.90075904 |
127 | Syncope (HP:0001279) | 1.88877102 |
128 | Metaphyseal dysplasia (HP:0100255) | 1.88457508 |
129 | Acute lymphatic leukemia (HP:0006721) | 1.88445274 |
130 | Abnormality of T cell physiology (HP:0011840) | 1.87853066 |
131 | Myoglobinuria (HP:0002913) | 1.87337488 |
132 | Prolonged QT interval (HP:0001657) | 1.87091860 |
133 | Myotonia (HP:0002486) | 1.87084141 |
134 | Vacuolated lymphocytes (HP:0001922) | 1.87061230 |
135 | Fatigable weakness (HP:0003473) | 1.86321587 |
136 | Abnormality of the neuromuscular junction (HP:0003398) | 1.86321587 |
137 | Muscle fiber atrophy (HP:0100295) | 1.85028722 |
138 | Enlarged penis (HP:0000040) | 1.84224525 |
139 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82329444 |
140 | IgG deficiency (HP:0004315) | 1.82197242 |
141 | Striae distensae (HP:0001065) | 1.82192167 |
142 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81583179 |
143 | Vertigo (HP:0002321) | 1.81284719 |
144 | Systemic lupus erythematosus (HP:0002725) | 1.80465596 |
145 | Loss of speech (HP:0002371) | 1.79143748 |
146 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78564196 |
147 | Abnormality of the endocardium (HP:0004306) | 1.78218011 |
148 | Abnormality of the calf musculature (HP:0001430) | 1.77924845 |
149 | Ventricular arrhythmia (HP:0004308) | 1.75862722 |
150 | Abnormality of potassium homeostasis (HP:0011042) | 1.75664166 |
151 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.73218992 |
152 | Renal cortical cysts (HP:0000803) | 1.69110456 |
153 | Ketoacidosis (HP:0001993) | 1.68933049 |
154 | Abnormality of the foot musculature (HP:0001436) | 1.68250692 |
155 | Waddling gait (HP:0002515) | 1.66587292 |
156 | Oligomenorrhea (HP:0000876) | 1.65788938 |
157 | Muscular dystrophy (HP:0003560) | 1.65204421 |
158 | Increased intramyocellular lipid droplets (HP:0012240) | 1.61114895 |
159 | Ankle clonus (HP:0011448) | 1.59849764 |
160 | Visual hallucinations (HP:0002367) | 1.59380826 |
161 | Increased muscle lipid content (HP:0009058) | 1.59211829 |
162 | Left ventricular hypertrophy (HP:0001712) | 1.58229079 |
163 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.58133864 |
164 | Long clavicles (HP:0000890) | 1.54168753 |
165 | Proximal amyotrophy (HP:0007126) | 1.51579653 |
166 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.49231538 |
167 | Hip contracture (HP:0003273) | 1.48893433 |
168 | Hyperglycemia (HP:0003074) | 1.48772216 |
169 | Foot dorsiflexor weakness (HP:0009027) | 1.48483915 |
170 | Hypokalemia (HP:0002900) | 1.46497297 |
171 | Hyperalaninemia (HP:0003348) | 1.43433492 |
172 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.43433492 |
173 | Abnormality of alanine metabolism (HP:0010916) | 1.43433492 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 3.13853088 |
2 | KIT | 3.03310978 |
3 | FLT3 | 2.99775693 |
4 | MAP4K1 | 2.94771422 |
5 | TNIK | 2.86529224 |
6 | ZAP70 | 2.37879940 |
7 | TAOK3 | 2.25057297 |
8 | INSRR | 2.20155486 |
9 | CSF1R | 2.10342994 |
10 | MAP2K3 | 2.01656426 |
11 | MUSK | 1.99664014 |
12 | BTK | 1.97071281 |
13 | TYK2 | 1.96662858 |
14 | TXK | 1.92711238 |
15 | PIK3CG | 1.90151325 |
16 | SYK | 1.88912713 |
17 | DAPK2 | 1.87160544 |
18 | TTN | 1.83851586 |
19 | PKN2 | 1.81470831 |
20 | EEF2K | 1.80734924 |
21 | MAP2K2 | 1.79176904 |
22 | PINK1 | 1.69789260 |
23 | TEC | 1.62245422 |
24 | CDK19 | 1.60824497 |
25 | CAMKK2 | 1.57477538 |
26 | JAK1 | 1.55935643 |
27 | TIE1 | 1.55048356 |
28 | SIK2 | 1.47918409 |
29 | LMTK2 | 1.36190912 |
30 | RIPK1 | 1.32565743 |
31 | TGFBR1 | 1.31328735 |
32 | FES | 1.28923084 |
33 | NME2 | 1.28915953 |
34 | IRAK4 | 1.28181929 |
35 | ITK | 1.26564091 |
36 | MYLK | 1.26115936 |
37 | JAK3 | 1.24261915 |
38 | LCK | 1.21476097 |
39 | CAMK1 | 1.20467035 |
40 | MAP3K13 | 1.16332704 |
41 | MAP2K4 | 1.15994692 |
42 | TBK1 | 1.12530776 |
43 | HCK | 1.12288650 |
44 | MAPK12 | 1.06740931 |
45 | SGK223 | 1.04970022 |
46 | SGK494 | 1.04970022 |
47 | GRK6 | 1.03814033 |
48 | MAP3K7 | 1.03776929 |
49 | PRKCH | 1.01884217 |
50 | ERN1 | 1.00525029 |
51 | IKBKE | 0.99582668 |
52 | HIPK2 | 0.99437569 |
53 | NLK | 0.98087507 |
54 | CAMKK1 | 0.97081275 |
55 | GRK7 | 0.96046047 |
56 | MAP2K6 | 0.95279090 |
57 | MATK | 0.92760899 |
58 | KDR | 0.89709051 |
59 | BMPR1B | 0.88506011 |
60 | PHKG1 | 0.88213060 |
61 | PHKG2 | 0.88213060 |
62 | CAMK4 | 0.86499101 |
63 | STK38 | 0.85694263 |
64 | CCNB1 | 0.85629256 |
65 | CDK6 | 0.82113887 |
66 | MAP3K12 | 0.81939102 |
67 | ERBB3 | 0.81686897 |
68 | IRAK3 | 0.81158009 |
69 | WNK1 | 0.79738745 |
70 | PRKAA2 | 0.79454723 |
71 | PDK1 | 0.79271430 |
72 | ADRBK2 | 0.78317999 |
73 | LYN | 0.78215160 |
74 | STK16 | 0.77336899 |
75 | KSR2 | 0.77171925 |
76 | SGK1 | 0.77148310 |
77 | SCYL2 | 0.75605855 |
78 | CAMK1G | 0.74641685 |
79 | CAMK1D | 0.74491836 |
80 | LRRK2 | 0.74391173 |
81 | TRIB3 | 0.72769010 |
82 | RIPK4 | 0.70318799 |
83 | MAPK15 | 0.69519779 |
84 | RPS6KB1 | 0.69421089 |
85 | PLK2 | 0.69137751 |
86 | DMPK | 0.68284429 |
87 | PRKAA1 | 0.67438167 |
88 | NME1 | 0.67270182 |
89 | MAPKAPK5 | 0.66793531 |
90 | MAP3K14 | 0.66527489 |
91 | DAPK1 | 0.66073769 |
92 | PIK3CA | 0.64910742 |
93 | MAPKAPK3 | 0.63568818 |
94 | PDPK1 | 0.62960397 |
95 | MAP2K1 | 0.62524221 |
96 | MAPK11 | 0.61000522 |
97 | TNK2 | 0.60612339 |
98 | TRPM7 | 0.60229192 |
99 | STK24 | 0.60103647 |
100 | DYRK1A | 0.59343953 |
101 | FRK | 0.58836006 |
102 | BCKDK | 0.58144196 |
103 | PDK2 | 0.56361671 |
104 | PRKD2 | 0.56238258 |
105 | CLK1 | 0.56166049 |
106 | JAK2 | 0.55758260 |
107 | MAPK7 | 0.55624662 |
108 | UHMK1 | 0.55207828 |
109 | NEK6 | 0.55129373 |
110 | OBSCN | 0.54233844 |
111 | STK10 | 0.53873510 |
112 | RPS6KC1 | 0.53269378 |
113 | RPS6KL1 | 0.53269378 |
114 | SIK3 | 0.52876161 |
115 | AKT3 | 0.52542253 |
116 | PRKG1 | 0.52433298 |
117 | STK11 | 0.52388300 |
118 | MAPK13 | 0.51443438 |
119 | NTRK3 | 0.51181349 |
120 | WNK4 | 0.51043668 |
121 | RPS6KA6 | 0.47942273 |
122 | SGK2 | 0.46649320 |
123 | RAF1 | 0.45873105 |
124 | MOS | 0.45230503 |
125 | CDK3 | 0.44837377 |
126 | DYRK1B | 0.44802443 |
127 | SGK3 | 0.43946875 |
128 | IKBKB | 0.43930358 |
129 | PIM1 | 0.43650602 |
130 | BRD4 | 0.42628971 |
131 | CAMK2A | 0.40489337 |
132 | RPS6KA3 | 0.40467742 |
133 | MARK2 | 0.40354150 |
134 | CAMK2G | 0.40027863 |
135 | RPS6KA1 | 0.40022203 |
136 | MAP3K10 | 0.39726744 |
137 | RPS6KA2 | 0.39344848 |
138 | MAP3K1 | 0.38874858 |
139 | MAP3K6 | 0.38846163 |
140 | PRKD1 | 0.38743782 |
141 | RET | 0.38267099 |
142 | CHUK | 0.37182307 |
143 | FGFR3 | 0.36859582 |
144 | YES1 | 0.36806525 |
145 | BMPR2 | 0.35531455 |
146 | PDGFRA | 0.35320077 |
147 | PRKACA | 0.34229211 |
148 | MAPK4 | 0.33677478 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.70946978 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92116070 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.47768753 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.04584064 |
5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.96363287 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94854352 |
7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.86029728 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78811108 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76977981 |
10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.71890094 |
11 | Platelet activation_Homo sapiens_hsa04611 | 1.71725122 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71441923 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61832525 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60626975 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53069384 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50299900 |
17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47542315 |
18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.46912001 |
19 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46527760 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46459965 |
21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44878495 |
22 | Peroxisome_Homo sapiens_hsa04146 | 1.43850522 |
23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43521106 |
24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43521024 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42754396 |
26 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42318681 |
27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38565828 |
28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37754288 |
29 | Renin secretion_Homo sapiens_hsa04924 | 1.37200579 |
30 | Measles_Homo sapiens_hsa05162 | 1.31476354 |
31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30536502 |
32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26716186 |
33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25278462 |
34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.24985695 |
35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21993207 |
36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21277239 |
37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20451268 |
38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.20400045 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19575515 |
40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18992999 |
41 | Insulin secretion_Homo sapiens_hsa04911 | 1.18029830 |
42 | Long-term depression_Homo sapiens_hsa04730 | 1.17465401 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17271836 |
44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15735448 |
45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14963635 |
46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11033942 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10249243 |
48 | Salivary secretion_Homo sapiens_hsa04970 | 1.09150101 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08385231 |
50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07115669 |
51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07089127 |
52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04047041 |
53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02573276 |
54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02520907 |
55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02381035 |
56 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00564401 |
57 | Insulin resistance_Homo sapiens_hsa04931 | 0.99855141 |
58 | Morphine addiction_Homo sapiens_hsa05032 | 0.99187330 |
59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97395521 |
60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.96993563 |
61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95232181 |
62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94958455 |
63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94317383 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94057862 |
65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93120621 |
66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92989668 |
67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91955761 |
68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90360223 |
69 | Lysosome_Homo sapiens_hsa04142 | 0.89348171 |
70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89334114 |
71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88503937 |
72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88494155 |
73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85198685 |
74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84362816 |
75 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.84041186 |
76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81341298 |
77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79575934 |
78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79346332 |
79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79122601 |
80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79091739 |
81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78975034 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78558260 |
83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77202677 |
84 | Tuberculosis_Homo sapiens_hsa05152 | 0.75996019 |
85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75974418 |
86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75399001 |
87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75287407 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74983649 |
89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74030712 |
90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73964723 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73924036 |
92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73793029 |
93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72930571 |
94 | Taste transduction_Homo sapiens_hsa04742 | 0.72708104 |
95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72492726 |
96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71453694 |
97 | Influenza A_Homo sapiens_hsa05164 | 0.70980559 |
98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70912388 |
99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68811769 |
100 | Pertussis_Homo sapiens_hsa05133 | 0.68331354 |
101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68201829 |
102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67305792 |
103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66160499 |
104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65783757 |
105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65020685 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65009103 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64829145 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64073170 |
109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.64058271 |
110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63178906 |
111 | ABC transporters_Homo sapiens_hsa02010 | 0.62956112 |
112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62849285 |
113 | Phototransduction_Homo sapiens_hsa04744 | 0.62196313 |
114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62073312 |
115 | Hepatitis B_Homo sapiens_hsa05161 | 0.61527990 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60525756 |
117 | Endocytosis_Homo sapiens_hsa04144 | 0.59795333 |
118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59604248 |
119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59216998 |
120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58990869 |
121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58082367 |
122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57311869 |
123 | Shigellosis_Homo sapiens_hsa05131 | 0.56689556 |
124 | Salmonella infection_Homo sapiens_hsa05132 | 0.56302317 |
125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55824077 |
126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55540263 |
127 | Allograft rejection_Homo sapiens_hsa05330 | 0.54979669 |
128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54455497 |
129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51783536 |
130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51354648 |
131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50620622 |
132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50587243 |
133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50312091 |
134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50256908 |
135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49056242 |
136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47674303 |
137 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45512114 |
138 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42683324 |
139 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42566621 |
140 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41488323 |
141 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40581906 |
142 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40382207 |
143 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39476952 |
144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38993190 |
145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38652613 |